quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:25:11·56d
SECFiling
Vera Therapeutics Inc. logo

SEC Form 10-K filed by Vera Therapeutics Inc.

VERA· Vera Therapeutics Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • VERA
    Vera Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Mar 11UpdateWolfe Research$88.00
  • Oct 16UpdateBofA Securities$48.00
  • Aug 4UpdateWolfe Research-
  • May 5UpdateH.C. Wainwright$75.00
  • Feb 4UpdateWolfe Research$49.00
  • Jan 28UpdateGoldman$58.00

Related

  • INSIDER8d
    SEC Form 4 filed by Fordyce Marshall
  • PR13d
    Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • SEC14d
    SEC Form DEFA14A filed by Vera Therapeutics Inc.
  • SEC14d
    SEC Form DEF 14A filed by Vera Therapeutics Inc.
  • SEC22d
    SEC Form SCHEDULE 13G filed by Vera Therapeutics Inc.
  • PR27d
    Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Vera Therapeutics Inc.
  • INSIDER29d
    SEC Form 4 filed by Wright-Mitchell Jane
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022